FCGR2B and autoimmune disease: In the past, it was shown that polymorphisms in the promoter and regulatory region of FCGRIIB are associated with a reduced expression of this receptor, which caused a higher susceptibility for autoimmune diseases (47–49) suggesting an important role for FcγRIIB in controlling B cell activity to prevent autoimmune responses.